Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, 09 1995, 598-603, Vol 2, No. 5
JL Shellhaas and SH Zuckerman
The human histiocytic lymphoma line HL-60 has served as a model of myeloid
cell differentiation and can be induced to differentiate along the
neutrophil or monocytic lineage, depending on the external stimulus. The
nondifferentiated cell line retains a premyeloid leukemic phenotype and is
capable of anchorage-independent growth and proliferation. The role of
apoptosis in the regulation of immunologic and inflammatory events
associated with homeostasis and disease has been most intensively studied
in lymphocytes. In the present study, nondifferentiated HL-60 has served as
a model for studying myeloid cell apoptosis by investigating apoptotic
changes induced by camptothecin, a DNA topoisomerase inhibitor, as well as
physiologic stimuli, including ceramide analogs and a monoclonal antibody
against the Fas antigen. Multiparameter flow cytometry was used to evaluate
apoptosis by measuring changes in both side scatter and propidium iodide
staining. The appearance of apoptotic cells was confirmed biochemically by
measuring DNA endonuclease activity by both enzyme-linked immunosorbent
assay quantitation and DNA ladder formation on agarose gels and
morphologically with the detection of micronuclei by confocal laser
microscopy. These studies demonstrate that HL-60 can serve as an in vitro
model for the detection of physiologic and pharmacologic apoptotic stimuli
and for understanding the early and late cellular changes associated with
induction of the apoptotic program.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
In vitro detection of apoptotic stimuli by use of the HL-60 myeloid leukemic cell line
Division of Cardiovascular Research, Lilly Research Labs, Indianapolis, Indiana 46285, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |